Skip to main content

Table 5 Device-oriented endpoint within 24 months

From: Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique

 

Total

Lesion length < 20 mm

Lesion length ≥20 mm

P-Value

Number of lesions

329

223

106

 

Scaffold thrombosis, N (%)

 
 

1 (0.3)

1 (0.4)

0 (0.0)

0.38

TLR, N (%)

14 (4.3)

5 (2.3)

9 (8.7)

0.03

MI, N (%)

7 (2.1)

4 (1.8)

3 (2.8)

0.15

Number of patients

247

146

101

 

DoCE, N (%)

18 (7.3)

8 (5.5)

10 (9.9)

0.19

Cardiac mortality, N (%)

3 (1.2)

2 (1.4)

1 (1.0)

0.96

  1. TLR ischemia-driven target lesion revascularization, MI myocardial infarction, not clearly related to a non-target vessel; DoCE device-oriented endpoints